期刊文献+

二去水卫矛醇的合成 被引量:2

Synthesis of dianhydrogalactitol
原文传递
导出
摘要 目的研究二去水卫矛醇的合成工艺。方法以植物提取的卫矛醇为起始原料,在0.16 mol·L-1溴酸溶液中进行溴代反应得到二溴卫矛醇(DBD),DBD和碳酸钾在叔丁醇中发生分子内消除反应得到二去水卫矛醇(DAG)粗品,经重结晶得到DAG纯品,并采用正交实验设计法对实验中所涉及的温度、溶剂用量和碱的用量等进行了优化。结果与结论本法原料易得,反应条件温和,后处理简便,适合放大生产,总收率为50%左右,产品纯度和有关物质均符合中华人民共和国药典规定。 Dianhydrogalactitol was synthesized from bromination of natural dulcitol in 0. 16 mol.L-1 hydrobromic acid solution to afford dibromodulcitol, which was subjected to intramolecular elimination with potassium carbonate, followed by recrystallization in n-butanol/acetone with satisfied overall yield. The content of purity and related substances meet the requirements of Chinese Pharmacopeia.
出处 《中国药物化学杂志》 CAS CSCD 2016年第2期109-111,共3页 Chinese Journal of Medicinal Chemistry
关键词 抗肿瘤药物 二去水卫矛醇 合成 antineoplastic drug dianhydrogalactitol synthesis
  • 相关文献

参考文献10

  • 1周瑛,潘启超.己糖醇类抗癌新药的研究进展[J].癌症,1993,12(3):257-260. 被引量:8
  • 2CHIUTEN D F, ROZENCWEIG M, Von HOFF D, et al. Clinical trials with the hexitol derivatives in the U. S. [J]. Cancer, 1981,47:442 -451. 被引量:1
  • 3BACHA J A, BROWN D M, GARNER W A. Veteri- nary use of dianhydrogalactitol, diacetyldianhydroga- lactitol, and dibromodulcitol to treat malignancies: 2013169600[P]. 2013 - 11 - 14. 被引量:1
  • 4ELSON L A, JARMAN M, ROSS W C J. Toxicity, haematological effects and anti-tumour activity ofepoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol [J]. Eur J Cancer,1968(4) :617 -625. 被引量:1
  • 5JARMAN M, ROSS W C J. The formation of epo- xides from substituted hexitols[J]. Carbohyd Res, 1969(9) :139 - 147. 被引量:1
  • 6BROWN D M. Method of synthesis of substituted hexitols such as dianhydrogalactitol: 2012024368 [P]. 2012 -02 -23. 被引量:1
  • 7BROWN D M. Method of synthesis of substituted hexitols such as dianhydrogalactitol: 20140155638 [P]. 2014 - 06 - 05. 被引量:1
  • 8国家药典委员会.国家药品标准[s].化学药品地标升国标.第15册.北京:中国医药科技出版社,2003:77. 被引量:1
  • 9国家药典委员会.国家药品标准[s].化学药品地标升国标.第8册.北京:中国医药科技出版社,2002:112. 被引量:1
  • 10魏宁漪,宁保明.气相色谱法测定注射用去水卫矛醇的含量及有关物质[J].中国药师,2011,14(9):1306-1307. 被引量:4

二级参考文献8

  • 1国家药品标准[s].化学药品地标升国标.第15册.2003.77. 被引量:1
  • 2国家药品标准[s].化学药品地标升国标.第8册.2002.112. 被引量:1
  • 3S. Kerpel-Fronius,V. Erdélyi-Tóth,S. Somfai-Relle,J. Csetényi,P. Kovács,G. Ujj,B. Kanyár. The role of comparative pharmacokinetics in the planning of human dose escalation: the experience with diacetyldianhydrogalactitol[J] 1988,Cancer Chemotherapy and Pharmacology(2):109~113 被引量:1
  • 4V. Erdélyi-Tóth,S. Kerpel-Fronius,B. Kanyár,S. Eckhardt. Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG)[J] 1986,Cancer Chemotherapy and Pharmacology(3):257~263 被引量:1
  • 5S. Kerpel-Fronius,V. Erdélyi-Tóth,F. Gyergyay,I. Hindy,Z. Mechl,M. Nekulová,S. Somfai-Relle,P. Kovács,Gy. Ujj,B. Kanyar,S. Eckhardt. Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)[J] 1986,Cancer Chemotherapy and Pharmacology(3):264~268 被引量:1
  • 6G. Mathé,L. M. Putten. New cancer chemotherapy drugs in Europe[J] 1978,Cancer Chemotherapy and Pharmacology(1):5~13 被引量:1
  • 7王悦,郝苏丽,杨化新,范慧红.首批还原型谷胱甘肽杂质国家对照品的研制[J].中国药事,2010,24(3):248-249. 被引量:4
  • 8徐奇超.GC法测定丁细牙痛胶囊中丁香酚的含量[J].中国药师,2011,14(1):72-73. 被引量:4

共引文献10

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部